Advanced Search

All Active Funding Opportunities

For questions regarding these opportunities, please contact Sarah Laye at: slaye@som.umaryland.edu.

Date Posted Organization Title Website Type LOI and/or Application Due Date Comments / Documents
07/08/22 NCI Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Link NIH Standard due dates apply LOI required and due 30 days prior to the application due date.
06/12/23 NCI Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed) Link NIH Applications are accepted by continuous receipt.
08/02/22 NCI Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) Link NIH Application due: 06/11/24 LOI due 30 days before application due date
10/07/22 NCI Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 30 days before application due date
12/20/22 NCI NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional) Link NIH Standard due dates apply no LOI required
05/07/24 NCI Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed) Link NIH Application due: 03/02/25
04/26/23 NCI Cancer Immunoprevention Network (CIP-Net) ​Research Projects (UG3/UH3 Clinical Trials Not Allowed) Link NIH Application due: 07/03/24 LOI due 30 days before application due date
08/04/22 NCI Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Link NIH Standard due dates apply Earliest due date for new applications is 10/5/22. LOI not required.
09/10/21 NCI Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Link NIH Standard due dates apply Next due date is 10/16/21.
08/04/22 NCI Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) Link NIH Standard due dates apply Next application deadline is 2/5/2023, LOI due 1/5/2023.
05/07/24 NCI The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional) Link NIH Application due: 06/18/24
04/10/23 NCI NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed) Link NIH Standard due dates apply
08/02/22 NCI The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Link NIH Standard due dates apply
08/11/23 NCI Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings Link NIH NOSI Application due: 11/18/25
09/18/20 NCI NCI Mentored Research Scientist Development Award to Promote Diversity (K01 -Independent Clinical Trial Not Allowed) Link NIH Standard due dates apply
12/13/23 NCI Notice of Special Interest (NOSI): National Cancer Institute Entrepreneurial Education Programs to Facilitate Commercialization of Cancer Relevant Technologies Link NIH NOSI Application due: 01/08/27
05/07/24 NCI Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) Link NIH Standard due dates apply
12/13/23 NCI Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project Link NIH NOSI Application due: 05/01/25
08/16/22 NCI Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) Link NIH Application due: 07/29/24
05/07/24 NCI Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) Link NIH Standard due dates apply
04/01/22 NCI Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) Link NIH Standard due dates apply
09/18/20 NCI NCI Transition Career Development Award to Promote Diversity (K22 No Independent Clinical Trials) Link NIH Standard due dates apply
12/13/23 NCI Assessment of Climate at Institutions (ACt) Award (RC2 - Clinical Trial Not Allowed) Link NIH Application due: 07/01/24 LOI due 30 days before application due date
08/02/22 NCI Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
01/17/24 NCI Notice of Special Interest (NOSI): Chronic Inflammation of the Oral Cavity - An Agent for Oral Mucosal Disease Link NIH NOSI Application due: 05/10/27
07/27/23 NCI Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects Link NIH NOSI Application due: 05/09/24
08/02/22 NCI Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 30 days before application due date
11/28/20 NCI Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) Link NIH Standard due dates apply
06/26/23 NCI Notice of Special Interest (NOSI): Research on HIV-associated Malignancies Link NIH NOSI Application due: 09/08/26
08/02/22 NCI Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) Link NIH Application due: 06/11/24 LOI due 30 days before application due date
01/09/23 NCI Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) Link NIH Standard due dates apply
07/22/22 NCI NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) Linnk NIH Standard due dates apply
12/20/23 NCI Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications Link NIH NOSI Application due: 01/27/27
03/11/24 NCI Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities Link NIH NOSI Application due: 10/10/26
12/05/22 NCI Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) Link NIH Application due: 06/14/24 LOI due 30 days before application due date
05/07/24 NCI Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project Link NIH NOSI Application due: 05/01/25
07/22/22 NCI The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) Link NIH Standard due dates apply
08/29/23 NCI Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) Link NIH Standard due dates apply
10/14/22 NCI Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) Link NIH Standard due dates apply
12/13/23 NCI NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) Link Foundation Application due: 06/14/24
10/14/22 NCI Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) Link NIH LOI due: 11/28/2022
05/07/24 NCI Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed) Link NIH Application due: 08/21/24
03/24/23 NCI Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects Link NIH NOSI Application due: 05/09/24
08/11/23 NCI Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
07/22/22 NCI Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) Link NIH Standard due dates LOI due 30 days prior to the application due date.
12/13/23 NCI Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute Link NIH NOSI Application due: 11/13/24
07/08/22 NCI Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors Link NIH NOSI Application due: 10/09/24 First Available Due Date: 3/7/22. Expiration Date: 10/9/24.
08/16/22 NCI Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Link NIH Application due: 07/29/24
05/07/24 NCI Notice of Special Interest (NOSI): Research Council of Finland (RCF) – National Institutes of Health (NIH) Partnership Program Link NIH NOSI Application due: 01/08/25
03/08/23 NCI Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments Link NIH NOSI Application due: 05/08/24
04/01/22 NCI Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 30 days prior to the application due date.
07/27/23 NCI Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments Link NIH NOSI Application due: 05/08/24
12/13/23 NCI Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 30 days before application due date
06/17/22 NCI Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) Link NIH Application due: 11/17/24
05/15/20 NCI Announcement of Availability to Investigators of Lutathera® (815530) For Clinical and Nonclinical Study Proposals Link NCI Lutathera__NSC815530_ Announcement_of_Availability.pdf23.96 KB
01/17/24 NCI Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences Link NIH NOSI Application due: 05/08/29
08/02/22 NCI Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) Link NIH Application due: 06/07/24 LOI due 30 days before application due date
04/01/22 NCI Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
01/17/24 NCI Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences Link NIH NOSI Application due: 05/08/29
03/31/24 NCI Notice of Special Interest (NOSI): Administrative Supplements for Assessing and Enhancing Survivorship Care Link NIH NOSI Application due: 06/05/24
11/28/20 NCI Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) Link NIH Standard due dates apply
07/11/23 NCI Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials Link NIH NOSI Application due: 07/01/25
08/02/22 NCI NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Link NIH Standard due dates apply
07/22/22 NCI Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Link NIH Application due: 06/11/24 LOI due 30 days before application due date
07/01/22 NCI Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) Link NIH Standard due dates apply LOI due 30 days before application due date
08/04/22 NCI National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) Link NIH Standard due dates apply LOI required and due 30 days prior to the application due date.
06/05/23 NCI Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities Link NIH NOSI Application due: 10/10/26
10/14/22 NCI Notice of Special Interest (NOSI): Expanding Cancer Control Research in Persistent Poverty Areas Link NOSI Expiration Date: 5/8/23
10/04/23 NCI Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk Link NIH NOSI Application due: 09/08/24
07/15/22 NCI Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) Link NIH Standard due dates
05/07/24 NCI Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity Link NIH NOSI Application due: 11/29/24
04/08/22 NCI Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
03/11/24 NCI NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) Link NIH Application due: 06/14/24
05/07/24 NCI Notice of Special Interest (NOSI): Administrative Supplements for NCI Center for Global Health Research Programs Link NIH NOSI Application due: 05/23/24
04/10/23 NCI Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) Link NIH Application due: 06/13/24 LOI due 30 days before application due date
04/29/22 NCI Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) Link NIH Standard due dates apply
08/11/23 NCI Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) Link NIH Standard due dates apply
09/18/20 NCI NCI Mentored Research Scientist Development Award to Promote Diversity (K01 - Clinical Trial Required) Link NIH Standard due dates apply
05/07/24 NCI Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research Link NIH NOSI Application due: 06/14/24
08/11/23 NCI Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply